利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.025 秒)

    Systems and Methods for Cloud Management
    2.
    发明申请
    Systems and Methods for Cloud Management 有权
    云管理系统与方法

    公开(公告)号：US20140047434A1

    公开(公告)日：2014-02-13

    申请号：US13572330

    申请日：2012-08-10

    申请人： Anthony Lam ,  Lars Trieloff ,  Pierre Tager ,  Heidi Chen ,  Joseph Lee ,  Alexander Klimetschek

    发明人： Anthony Lam ,  Lars Trieloff ,  Pierre Tager ,  Heidi Chen ,  Joseph Lee ,  Alexander Klimetschek

    IPC分类号： G06F9/445 ,  G06F15/16

    CPC分类号： G06F9/5072 ,  G06F8/61 ,  G06F9/44505

    摘要： Systems and methods for cloud management are disclosed. For example, one disclosed method includes the steps of receiving access information for a cloud service provider; receiving configuration information for a cloud instance; receiving a command to create the cloud instance; requesting and receiving a node from the cloud service provider; causing the node to be configured as a cloud node, comprising causing a software package to be installed and configured on the cloud node; configuring the cloud instance and incorporating the node into the cloud instance; and providing access to the cloud instance.

    摘要翻译： 披露了云管理的系统和方法。 例如，一种公开的方法包括以下步骤：接收云服务提供商的访问信息; 接收云实例的配置信息; 接收创建云实例的命令; 从云服务提供商请求和接收节点; 使得所述节点被配置为云节点，包括使得在所述云节点上安装和配置软件包; 配置云实例并将节点合并到云实例中; 并提供对云实例的访问。

    Aminoalkoxyphenyl indolone derivatives
    3.
    发明申请
    Aminoalkoxyphenyl indolone derivatives 审中-公开
    氨基烷氧基苯基吲哚酮衍生物

    公开(公告)号：US20060172989A1

    公开(公告)日：2006-08-03

    申请号：US11049591

    申请日：2005-02-02

    申请人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen ,  Upendra Topiwala ,  Hermogenes Jimenez ,  Jamie Talisman

    发明人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen ,  Upendra Topiwala ,  Hermogenes Jimenez ,  Jamie Talisman

    IPC分类号： A61K31/5377 ,  A61K31/496 ,  A61K31/404 ,  C07D413/02 ,  C07D403/02

    CPC分类号： C07D209/34 ,  C07D403/12 ,  C07D405/12

    摘要： This invention is directed to aminoalkoxyphenyl indolone derivatives which are ligands at the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/ or anxiety which comprises administering to the subject an amount of a compound of the subject invention.

    摘要翻译： 本发明涉及作为GAL 3受体的配体的氨基烷氧基苯基吲哚酮衍生物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。 本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。 本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括给予受试者一定量的本发明化合物。

    Systems and methods for cloud management
    4.
    发明授权
    Systems and methods for cloud management 有权
    云管理系统和方法

    公开(公告)号：US09292352B2

    公开(公告)日：2016-03-22

    申请号：US13572330

    申请日：2012-08-10

    申请人： Anthony Lam ,  Lars Trieloff ,  Pierre Tager ,  Heidi Chen ,  Joseph Lee ,  Alexander Klimetschek

    发明人： Anthony Lam ,  Lars Trieloff ,  Pierre Tager ,  Heidi Chen ,  Joseph Lee ,  Alexander Klimetschek

    IPC分类号： G06F9/445 ,  G06F15/173 ,  G06F3/00 ,  G06F9/50

    CPC分类号： G06F9/5072 ,  G06F8/61 ,  G06F9/44505

    摘要： Systems and methods for cloud management are disclosed. For example, one disclosed method includes the steps of receiving access information for a cloud service provider; receiving configuration information for a cloud instance; receiving a command to create the cloud instance; requesting and receiving a node from the cloud service provider; causing the node to be configured as a cloud node, comprising causing a software package to be installed and configured on the cloud node; configuring the cloud instance and incorporating the node into the cloud instance; and providing access to the cloud instance.

    摘要翻译： 披露了云管理的系统和方法。 例如，一种公开的方法包括以下步骤：接收云服务提供商的访问信息; 接收云实例的配置信息; 接收创建云实例的命令; 从云服务提供商请求和接收节点; 使得所述节点被配置为云节点，包括使得在所述云节点上安装和配置软件包; 配置云实例并将节点合并到云实例中; 并提供对云实例的访问。

    Bottle cleaning system and method of use
    6.
    发明授权
    Bottle cleaning system and method of use 有权

    公开(公告)号：US11020779B1

    公开(公告)日：2021-06-01

    申请号：US16524474

    申请日：2019-07-29

    申请人： Heidi Chen

    发明人： Heidi Chen

    IPC分类号： B08B9/36 ,  B08B9/08 ,  B08B9/087 ,  A47L15/00

    摘要： A bottle cleaning system includes a bowl; and a brush attachment attached to the bottom surface of the bowl, and having an elongated tube attached to a rod engaged with a pressure seat, the pressure seat attached to a first valve; bristles extending from the elongated tube; a housing extending around the rod and positioned above the pressure seat; and a connection system attached to the bottom surface of the bowl, and having a plate with a channel, the channel to align with the pressure seat; and a spring surrounding the channel and having a second valve contained therein; depressing the spring via the housing forces liquid through the channel and the elongated tube; the bristles allow for one handed cleaning of a bottle.

    Aminoalkylphenyl indolone derivatives
    8.
    发明申请
    Aminoalkylphenyl indolone derivatives 审中-公开
    氨基烷基苯基吲哚酮衍生物

    公开(公告)号：US20060173192A1

    公开(公告)日：2006-08-03

    申请号：US11343989

    申请日：2006-01-31

    申请人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen

    发明人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen

    IPC分类号： C07D403/02

    CPC分类号： C07D209/40 ,  C07D403/10

    摘要： This invention is directed to aminoalkylphenyl indolone derivatives which are ligands at the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the subject invention.

    摘要翻译： 本发明涉及作为GAL 3受体的配体的氨基烷基苯基吲哚酮衍生物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。 本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。 本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括给予受试者一定量的本发明化合物。

    Aminoalkoxyphenyl indolone derivatives
    9.
    发明申请
    Aminoalkoxyphenyl indolone derivatives 审中-公开
    氨基烷氧基苯基吲哚酮衍生物

    公开(公告)号：US20060173180A1

    公开(公告)日：2006-08-03

    申请号：US11343810

    申请日：2006-01-31

    申请人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen ,  Upendra Topiwala ,  Hermogenes Jimenez ,  Jamie Talisman

    发明人： Michael Konkel ,  Mathivanan Packiarajan ,  Heidi Chen ,  Upendra Topiwala ,  Hermogenes Jimenez ,  Jamie Talisman

    IPC分类号： C07D413/02 ,  C07D403/02

    CPC分类号： C07D403/12 ,  C07D209/34 ,  C07D209/40 ,  C07D401/12

    摘要： This invention is directed to aminoalkoxyphenyl indolone derivatives, which are ligands at the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the subject invention.

    摘要翻译： 本发明涉及作为GAL 3受体的配体的氨基烷氧基苯基吲哚酮衍生物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。 本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。 本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括给予受试者一定量的本发明化合物。